Natural killer cells are characterized by the concomitantly increased interferon-γ and cytotoxicity in acute resolved hepatitis B patients

PLoS One. 2012;7(11):e49135. doi: 10.1371/journal.pone.0049135. Epub 2012 Nov 1.

Abstract

Natural killer (NK) cells are abundant in the liver and have been implicated in inducing hepatocellular damage in patients with chronic hepatitis B virus (HBV) infection. However, the role of NK cells in acute HBV infection remains to be elucidated. We comprehensively characterized NK cells and investigated their roles in HBV clearance and liver pathology in 19 chronic hepatitis B (CHB) patients and 21 acute hepatitis B (AHB) patients as well as 16 healthy subjects. It was found that NKp46(+) NK cells were enriched in the livers of AHB and CHB patients. We further found that peripheral NK cells from AHB patients expressed higher levels of activation receptors and lower levels of inhibitory receptors than those from CHB patients and HC subjects, thus displaying the increased cytolytic activity and interferon-γ production. NK cell activation levels were also correlated positively with serum alanine aminotransferase levels and negatively with plasma HBV DNA levels in AHB patients, which is further confirmed by the longitudinal follow-up of AHB patients. Serum pro-inflammatory cytokine and chemokine levels were also increased in AHB patients as compared with CHB and HC subjects. Thus, the concomitantly increased interferon-γ and cytotoxicity of NK cells were associated with liver injury and viral clearance in AHB patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • CD56 Antigen / biosynthesis
  • DNA, Viral / genetics
  • Female
  • Flow Cytometry
  • Hepatitis B / blood*
  • Hepatitis B / therapy*
  • Hepatitis B, Chronic / blood*
  • Hepatitis B, Chronic / therapy*
  • Humans
  • Immunohistochemistry / methods
  • Inflammation
  • Interferon-gamma / metabolism*
  • Killer Cells, Natural / cytology*
  • Liver / pathology
  • Male
  • Middle Aged

Substances

  • CD56 Antigen
  • DNA, Viral
  • Interferon-gamma

Grants and funding

This study was funded in full by the National Natural Science Foundation of China (30972752, 81172779), in part by the National Key Basic Research Program of China (No. 2012CB519005) and the National Grand Program on Key Infectious Disease (No. 2012ZX10002007-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.